Article
Long-term repopulation of peripheral B-cell subsets after single and repeated rituximab infusions in patients with rheumatoid arthritis.
Clinical and experimental rheumatology - 1 Jan 2000
Roll Petra, Mahmood Zafar, Muhammad Khalid, Feuchtenberger Martin, Dörner Thomas, Tony Hans-Peter
Abstract excerpt
OBJECTIVES: B-cell depletion using rituximab (RTX) has proven efficacy in patients with RA. Long-term effects on the B-cell system after single and repeated treatments are sparse. Our aim was to study the effect of multiple courses of rituximab to evaluate its impact on repeated B-cell re-population capacity. METHODS: Two cohorts, altogether 20 patients with RA were included in an open label extension study with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
